2H-Pyran-2-one, 5,6-dihydro-4-methoxy-6-[(1E)-2-phenylethenyl]-, 95%, 250mg

(2S,3R,4S,5S,6R)-2-((5-Bromo-4-chloro-1H-indol-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, 98%, 5g

2-Chloro-5-fluoro-3-methylbenzaldehyde, 97%, 10g

2,5-DIMETHYLPYRIMIDINE-4,6-DIOL, 95.0%, 1g

2-chloro-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)acetamide, 5g

1,6-Diaminohexane>99.0%(GC)(T)500g

2-(6-Fluoro-2-methyl-1H-1,3-benzodiazol-1-yl)acetic acid, 1g

(+/-)-2-Azabicyclo[2.2.1]hept-5-en-3-one, 98.00%, 100g

(R)-1-(tert-Butoxycarbonyl)-3,3-dimethylazetidine-2-carboxylic acid, 98%, 500mg

Tetraethyl Orthosilicate>98.0%(GC)25mL

Triphenylphosphinechlorogold, 98%, 2.5g

1,3,5-Tris(3,3,3-trifluoropropyl)-1,3,5-trimethylcyclotrisiloxane>98.0%(GC)25g

1-Phenyl-4-amino-5-chloro-6-pyridazone, 95.0%, 100g